These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17315855)

  • 1. Synthesis and biological evaluation of selective aromatase expression regulators in breast cancer cells.
    Su B; Landini S; Davis DD; Brueggemeier RW
    J Med Chem; 2007 Apr; 50(7):1635-44. PubMed ID: 17315855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition.
    Su B; Diaz-Cruz ES; Landini S; Brueggemeier RW
    J Med Chem; 2006 Feb; 49(4):1413-9. PubMed ID: 16480277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel sulfonanilide analogs decrease aromatase activity in breast cancer cells: synthesis, biological evaluation, and ligand-based pharmacophore identification.
    Su B; Tian R; Darby MV; Brueggemeier RW
    J Med Chem; 2008 Mar; 51(5):1126-35. PubMed ID: 18271519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective regulation of aromatase expression for drug discovery.
    Brueggemeier RW; Su B; Darby MV; Sugimoto Y
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):207-10. PubMed ID: 19931613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead optimization of COX-2 inhibitor nimesulide analogs to overcome aromatase inhibitor resistance in breast cancer cells.
    Su B; Chen S
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6733-5. PubMed ID: 19854050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase and COX in breast cancer: enzyme inhibitors and beyond.
    Brueggemeier RW; Su B; Sugimoto Y; Díaz-Cruz ES; Davis DD
    J Steroid Biochem Mol Biol; 2007; 106(1-5):16-23. PubMed ID: 17616393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
    Prosperi JR; Robertson FM
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
    Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
    Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.
    Brueggemeier RW; Díaz-Cruz ES
    Minerva Endocrinol; 2006 Mar; 31(1):13-26. PubMed ID: 16498361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules.
    Ghorab MM; Alsaid MS; Samir N; Abdel-Latif GA; Soliman AM; Ragab FA; Abou El Ella DA
    Eur J Med Chem; 2017 Jul; 134():304-315. PubMed ID: 28427017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    Ahmad I; Shagufta
    Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors.
    Di Matteo M; Ammazzalorso A; Andreoli F; Caffa I; De Filippis B; Fantacuzzi M; Giampietro L; Maccallini C; Nencioni A; Parenti MD; Soncini D; Del Rio A; Amoroso R
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3192-3194. PubMed ID: 27161804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Hydroxyphenylretinamide (4HPR) derivatives regulate aromatase activity and expression in breast cancer cells.
    Su B; Mershon SM; Stonerock LA; Curley RW; Brueggemeier RW
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):40-6. PubMed ID: 18248980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells.
    Díaz-Cruz ES; Shapiro CL; Brueggemeier RW
    J Clin Endocrinol Metab; 2005 May; 90(5):2563-70. PubMed ID: 15687328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual aromatase-steroid sulfatase inhibitors.
    Woo LW; Bubert C; Sutcliffe OB; Smith A; Chander SK; Mahon MF; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2007 Jul; 50(15):3540-60. PubMed ID: 17580845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors.
    Fantacuzzi M; De Filippis B; Gallorini M; Ammazzalorso A; Giampietro L; Maccallini C; Aturki Z; Donati E; Ibrahim RS; Shawky E; Cataldi A; Amoroso R
    Eur J Med Chem; 2020 Jan; 185():111815. PubMed ID: 31732252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors.
    Pingaew R; Prachayasittikul V; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Bioorg Med Chem; 2015 Jul; 23(13):3472-80. PubMed ID: 25934226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
    Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
    Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A positive feedback pathway of estrogen biosynthesis in breast cancer cells is contained by resveratrol.
    Wang Y; Ye L; Leung LK
    Toxicology; 2008 Jun; 248(2-3):130-5. PubMed ID: 18462857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 inhibitor nimesulide analogs are aromatase suppressors in breast cancer cells.
    Su B; Cai X; Hong Y; Chen S
    J Steroid Biochem Mol Biol; 2010 Oct; 122(4):232-8. PubMed ID: 20542113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.